Navigation Links
Cycle Technologies Announces New Article Addressing Reasons Why Many Women in the U.S. Are Not Using Contraception

(PRWEB) September 23, 2013

Cycle Technologies announced a new article on the CycleBeads Blog which reviews reasons many women in the U.S. are not using contraception for preventing pregnancy despite the fact that they do not want to get pregnant. Even though most sexually-active women in the United States have used contraception, there are still more than 3 million unplanned pregnancies each year. According to the most recent National Health Statistics Report, most unplanned pregnancies occur to women who are either not using contraception or are using it inconsistently.

The article outlines the top reasons women cite most often for not using family planning and how the natural family planning option CycleBeads® can address the situation. The reasons women give for not using contraception despite not wanting to get pregnant include:

  • "Did not think you could get pregnant."
  • "Worried about side effects of birth control."
  • "Not expecting to have intercourse."
Studies show that most women do not know when they can get pregnant. Most women can’t answer simple questions such as "When do I ovulate?" and "When will I be fertile?" CycleBeads tools help a woman see clearly and easily when pregnancy is possible during her cycle. The technology can also help women determine whether or not their cycles are irregular.

Based on a natural family planning method called the Standard Days Method®, CycleBeads tools enable a woman to prevent pregnancy simply by understanding which days she is potentially fertile. As a fertility awareness-based family planning method, it does not have side-effects. Most women who choose this natural birth control option, say that their main reason for choosing it is that it is "safe" and "causes no side-effects."

"For those women who say that they ‘did not expect to have intercourse’, taking birth control daily can seem unnecessary. They may not be willing to put up with the side effects or cost of hormonal contraception given that they are not expecting to have intercourse. Additionally, they may not be prepared with a back-up method such as a condom," says Ann Mullen, Director of Client Services at Cycle Technologies. "CycleBeads can help in that they do not require a daily action. A woman simply tracks the first day of her period each cycle, and then can check on any given day as needed to see if she is on a day when pregnancy is possible. CycleBeads tools can help her plan for her fertile days so she is prepared ‘just in case’."

95% of the 3.2 million unintended pregnancies which occur each year in the U.S. are due to women using contraception inconsistently or not at all. More statistics are shown on the blog which can be found here:

About the Company:

Cycle Technologies’ mission is to bring to market products that help people live healthier lives. Cycle Technologies is the manufacturer and distributor of CycleBeads®, CycleBeads® Online, and iCycleBeads™ smartphone apps, patented tools based on the Standard Days Method® of family planning. These products provide women with easy to use information that allows them to plan or prevent pregnancy naturally. As a fertility awareness-based family planning option, CycleBeads educates women about their cycles and helps them manage their fertility without chemicals or hormones. It fulfills an unmet need for a natural family planning method that is easy to use, inexpensive, side effect-free, and highly effective. Women all over the world use these simple tools to help them understand their cycles and easily identify the days when pregnancy is possible.

For more information, please visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. No Progress in Reducing U.S. Motorcycle Deaths: Report
2. Stopping and starting cancer cell cycle weakens and defeats multiple myeloma
3. Freezing all embryos in IVF with transfer in a later non-stimulated cycle may improve outcome
4. Menstrual Cycles May Affect Womens Shopping Patterns
5. Respiratory symptoms vary according to stage of menstrual cycle
6. Womens Respiratory Symptoms May Vary With Menstrual Cycle
7. Timing of first menstrual cycle may be predictor of cardiovascular disease risk in women
8. NJ Accident Lawyers at Console & Hollawell React to New Motorcycle Crash Data from the U.S. Government Accountability Office
9. Delkin Devices Inc. Announces SPAN™ Extended Life Cycle Industrial Storage Product Line
10. Adult Tricycles Designed by Freedom Concepts Now Offered by
11. ACP urges Congress to create solution to endless cycle of medical physician payment cuts
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... the 1980s we have seen vast improvements in scientific research and discoveries, leading ... strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of volumetric ... the focus of numerous abstracts accepted for presentation here, at the 101st Annual ... abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools for ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... , ... XTC Semifinals 2016 - CES, Las Vegas, Nevada - ... CES 2016, the world’s largest Consumer Electronic Show, where they will present to a ... of Pacific Investments Veronica Serra, and venture capitalist Tim Draper among many other top ...
(Date:12/1/2015)... ... 2015 , ... SonaCare Medical congratulates the University College London ... on November 18th. This prestigious award recognizes annually organizations that cultivate truly innovative ... medical landscape. , The UCLH team won the award for their innovative approach ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , December 1, 2015 ... new market research report "Nucleic Acid Labeling Market by ... Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription, ... published by MarketsandMarkets, The global market is expected to ... Million in 2015, growing at a CAGR of 8.65%. ...
(Date:12/1/2015)... , December 1, 2015 Russia ... clinical trials. 70% of new drugs registered in Europe ... Russia . --> Russia has always been ... of new drugs registered in Europe in 2015 ... --> Russia has always been a country ...
(Date:12/1/2015)... 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... announced today that the company will present at the LD ... at the Luxe Sunset Boulevard Hotel in Los ... Relmada Therapeutics, will present on Thursday, December 3, at 9:00 ... . Please register at least 10 minutes prior to the ...
Breaking Medicine Technology: